BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 22008146)

  • 1. Drug release from extruded solid lipid matrices: theoretical predictions and independent experiments.
    Güres S; Siepmann F; Siepmann J; Kleinebudde P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):122-9. PubMed ID: 22008146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling drug release from PVAc/PVP matrix tablets.
    Siepmann F; Eckart K; Maschke A; Kolter K; Siepmann J
    J Control Release; 2010 Jan; 141(2):216-22. PubMed ID: 19737588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug release mechanisms of compressed lipid implants.
    Kreye F; Siepmann F; Siepmann J
    Int J Pharm; 2011 Feb; 404(1-2):27-35. PubMed ID: 21055453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution from solid lipid extrudates containing release modifiers.
    Güres S; Kleinebudde P
    Int J Pharm; 2011 Jun; 412(1-2):77-84. PubMed ID: 21515350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of artificial neural networks (ANNs) and genetic programming (GP) for prediction of drug release from solid lipid matrices.
    Güres S; Mendyk A; Jachowicz R; Dorożyński P; Kleinebudde P
    Int J Pharm; 2012 Oct; 436(1-2):877-9. PubMed ID: 22728260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mathematical model quantifying drug release from lipid implants.
    Siepmann F; Herrmann S; Winter G; Siepmann J
    J Control Release; 2008 Jun; 128(3):233-40. PubMed ID: 18442866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
    Klose D; Siepmann F; Elkharraz K; Siepmann J
    Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide.
    Almeida A; Brabant L; Siepmann F; De Beer T; Bouquet W; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Nov; 82(3):526-33. PubMed ID: 22986082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release implants based on cast lipid blends.
    Kreye F; Siepmann F; Zimmer A; Willart JF; Descamps M; Siepmann J
    Eur J Pharm Sci; 2011 May; 43(1-2):78-83. PubMed ID: 21463679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of extended release Kollidon SR mini-matrices prepared by hot-melt extrusion.
    Ozgüney I; Shuwisitkul D; Bodmeier R
    Eur J Pharm Biopharm; 2009 Sep; 73(1):140-5. PubMed ID: 19406237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited drug solubility can be decisive even for freely soluble drugs in highly swollen matrix tablets.
    Siepmann F; Karrout Y; Gehrke M; Penz FK; Siepmann J
    Int J Pharm; 2017 Jun; 526(1-2):280-290. PubMed ID: 28487190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictability of drug release from water-insoluble polymeric matrix tablets.
    Grund J; Körber M; Bodmeier R
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):650-5. PubMed ID: 23985775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled drug release from Gelucire-based matrix pellets: experiment and theory.
    Siepmann F; Muschert S; Flament MP; Leterme P; Gayot A; Siepmann J
    Int J Pharm; 2006 Jul; 317(2):136-43. PubMed ID: 16621362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs acting as plasticizers in polymeric systems: a quantitative treatment.
    Siepmann F; Le Brun V; Siepmann J
    J Control Release; 2006 Oct; 115(3):298-306. PubMed ID: 17045358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
    Miranda A; Millán M; Caraballo I
    Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.
    Ahuja N; Katare OP; Singh B
    Eur J Pharm Biopharm; 2007 Jan; 65(1):26-38. PubMed ID: 16962750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.